Research programme: anti-infectives - 4SC Discovery/AiCuris/CRELUX
Alternative Names: Anti-infectious therapeutics - 4SC Dicovery/AiCuris/CRELUXLatest Information Update: 28 Jul 2018
At a glance
- Originator 4SC Discovery; AiCuris; CRELUX
- Class Small molecules
- Mechanism of Action Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Infections in Germany
- 15 Apr 2016 CRELUX has been acquired by WuXi AppTec
- 04 Nov 2013 AiCuris, CRELUX and 4SC Discovery form a research collaboration to develop small molecule therapeutics for the treatment of Infections